Request for Applications: Research Grant Program

The PKD Foundation Research Grants 2026 support innovative research focused on autosomal dominant polycystic kidney disease (ADPKD) and autosomal recessive polycystic kidney disease (ARPKD). Eligible investigators can receive up to $240,000 over two years, while early-career researchers may qualify for the Young Investigator Award, providing up to $360,000 over three years to advance research on disease mechanisms, treatments, and patient outcomes.

About the PKD Foundation Research Grants

The PKD Foundation Research Grants are designed to accelerate scientific discoveries that improve the understanding, prevention, diagnosis, and treatment of polycystic kidney disease (PKD).

The programme supports innovative research across the full spectrum of PKD science, from laboratory-based studies to clinical and translational research. Funding is awarded through a competitive peer-review process to investigators with strong research proposals that have the potential to improve patient care and advance the field.

Applicants must first submit a Letter of Intent (LOI), and only invited applicants will be eligible to submit a full proposal.

Programme Objectives

The grant programme aims to:

• Advance knowledge of PKD biology.
• Support the development of new therapies.
• Improve diagnosis and disease management.
• Encourage innovative translational and clinical research.
• Promote early-career investigator development.
• Accelerate research that benefits individuals living with PKD.

Research Priority Areas

The programme supports research in areas including:

• Basic research
• Translational research
• Clinical research
• Epidemiology
• Data analysis research
• Autosomal Dominant Polycystic Kidney Disease (ADPKD)
• Autosomal Recessive Polycystic Kidney Disease (ARPKD)
• ADPKD in children
• Cilia signaling and cyst development
• Drug delivery mechanisms
• Protein dosage therapies
• Gene therapies
• Machine learning applications in PKD research
• Lifestyle interventions
• Disease progression
• Biomarkers
• Extra-renal manifestations of PKD

Extra-Renal Research Topics

Projects may also focus on:

• Congenital hepatic fibrosis
• Polycystic liver disease
• Intracranial aneurysms

Funding Information

Standard Research Grant

• Funding Amount: $120,000 per year
• Duration: 2 years
• Total Funding: $240,000 (direct costs only)

Young Investigator Award

Eligible early-career investigators may receive:

• Up to $360,000
• Funding period of 3 years

No indirect costs are permitted under either funding mechanism.

Allowable Budget Expenses

Funding may be used for eligible direct research expenses, including:

• Personnel salaries
• Laboratory supplies
• Research materials
• Consultant services
• Equipment
• Travel related to the research project

Budget Limits

• Salary support: Maximum 50% of direct costs
• Consultant fees: Up to $10,000
• Equipment: Up to $12,000
• Travel: Up to $1,500 per year

Applicants may request additional travel funding for conference participation when appropriately justified.

Young Investigator Award Requirements

To qualify for the Young Investigator Award, applicants must:

• Be early-career investigators.
• Have completed research training within the previous seven years.
• Provide an institutional letter confirming:
  • Institutional support.
  • A pathway toward research independence.
• Not hold a major independent research grant or equivalent career development award at the time funding begins.

Who is Eligible?

Applicants must:

• Hold an M.D., Ph.D., or equivalent degree.
• Hold a faculty appointment or equivalent position at the host institution by the award start date.
• Submit only one proposal during each funding cycle.
• Complete the required Letter of Intent (LOI).

Applicants are not required to be United States citizens.

Researchers from eligible institutions worldwide are encouraged to apply.

Application Process

The application consists of two stages.

Stage 1: Letter of Intent (LOI)

Applicants must submit a pre-application outlining:

• Research concept
• Objectives
• Scientific significance

Only selected applicants will receive an invitation to continue.

Stage 2: Full Proposal

Invited applicants submit a complete proposal including:

• Research plan
• Budget
• Supporting documents
• Institutional information
• Investigator qualifications

Resubmission Policy

Applicants whose proposals are not funded may submit:

• One revised application

The revised submission must include:

• A one-page response addressing reviewer comments.

After one resubmission, any future proposal must be submitted as a completely new application.

How to Apply

Step 1: Confirm Eligibility

Ensure that you:

• Hold the required academic degree.
• Meet faculty appointment requirements.
• Qualify for the standard or Young Investigator programme.

Step 2: Prepare Your Letter of Intent

Develop a concise overview describing:

• Research objectives.
• Scientific rationale.
• Innovation.
• Expected impact.

Step 3: Submit the LOI

Submit the Letter of Intent before the application deadline.

Step 4: Prepare the Full Proposal

If invited, prepare:

• Detailed research plan
• Budget
• Institutional documentation
• Supporting materials

Step 5: Submit the Full Application

Complete the invited application according to programme requirements.

Why This Grant Matters

The PKD Foundation Research Grants help researchers:

• Advance understanding of polycystic kidney disease.
• Develop new treatments and therapies.
• Improve patient outcomes.
• Explore innovative technologies such as machine learning and gene therapy.
• Build research careers through competitive funding.

The Young Investigator Award also strengthens the pipeline of future leaders in PKD research by supporting early-career investigators as they establish independent research programmes.

Tips for a Strong Application

Applicants should:

• Present a clearly defined research question.
• Demonstrate scientific innovation.
• Explain the potential impact on PKD diagnosis or treatment.
• Develop a realistic research timeline.
• Prepare a well-justified budget.
• Clearly address reviewer comments when submitting a revised application.

Common Mistakes to Avoid

Avoid these common errors:

• Submitting more than one proposal during a funding cycle.
• Exceeding budget limitations.
• Omitting required institutional documentation.
• Failing to submit the mandatory Letter of Intent.
• Applying for the Young Investigator Award without meeting career-stage requirements.
• Ignoring reviewer feedback in a resubmission.

Frequently Asked Questions (FAQs)

1. What is the PKD Foundation Research Grant?

It is a competitive research funding programme supporting studies that improve understanding and treatment of autosomal dominant and autosomal recessive polycystic kidney disease.

2. How much funding is available?

The Standard Research Grant provides $240,000 over two years, while the Young Investigator Award offers up to $360,000 over three years.

3. What research topics are eligible?

Eligible topics include basic, translational, clinical, epidemiological, and data-driven research related to PKD, including gene therapy, machine learning, cilia biology, pediatric PKD, and extra-renal manifestations.

4. Who can apply?

Applicants must hold an M.D., Ph.D., or equivalent degree, have a faculty or equivalent appointment by the award date, and submit only one proposal per funding cycle. International applicants are eligible.

5. Is a Letter of Intent required?

Yes. Submission of a Letter of Intent (LOI) is mandatory, and only invited applicants may submit a full proposal.

6. Are indirect costs allowed?

No. The programme funds direct research costs only, and indirect costs are not permitted.

7. What are the eligibility requirements for the Young Investigator Award?

Applicants must have completed their training within the previous seven years, receive institutional support toward independence, and must not hold major independent research grants when funding begins.

Conclusion

The PKD Foundation Research Grants 2026 provide significant funding opportunities for investigators dedicated to advancing research on autosomal dominant and autosomal recessive polycystic kidney disease. With support of up to $240,000 for standard research projects and up to $360,000 for early-career investigators, the programme encourages innovative research spanning basic science, clinical studies, gene therapy, machine learning, and translational medicine. Through its competitive funding model, the PKD Foundation continues to accelerate discoveries that improve the lives of individuals affected by polycystic kidney disease.